Richard Pilot
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Chronic Myeloid Leukemia Treatments 2
- Acute Myeloid Leukemia Research 1
- Blood groups and transfusion 1
- Genetics 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Hemoglobinopathies and Related Disorders 2
- Co-authors
- Jane F. Apperley (2 shared papers)Hagop M. Kantarjian (2 shared papers)Alan K. Hatfield (2 shared papers)Gianantonio Rosti (2 shared papers)Jörge E. Cortes (2 shared papers)Patricia Ault (1 shared paper)Mark A. Socinski (2 shared papers)Amy Ko (1 shared paper)
- Journals
- Blood (2 papers)Frontiers in Oncology (1 paper)European Journal of Cancer (1 paper)British Journal of Clinical Pharmacology (1 paper)Advances in Therapy (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Richard Pilot
9 papers receiving 358 citations
Peers
Comparison fields: 5 of 62
- Hematology 172
- Genetics 59
- Oncology 144
- Rheumatology 72
- Public Health, Environmental and Occupational Health 88
Countries citing papers authored by Richard Pilot
This map shows the geographic impact of Richard Pilot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Pilot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Pilot more than expected).
Fields of papers citing papers by Richard Pilot
This network shows the impact of papers produced by Richard Pilot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Pilot. The network helps show where Richard Pilot may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Pilot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 251 | |
| 2 | 2015 | 32 | |
| 3 | 2015 | 31 | |
| 4 | 2016 | 27 | |
| 5 | 2016 | 21 | |
| 6 | 2021 | 5 | |
| 7 | 2006 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2025 | 1 | |
| 10 | 2025 | 0 |
About Richard Pilot
Richard Pilot is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 371 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Cancer Risks and Factors (2 papers), Acute Myeloid Leukemia Research (1 paper), Lung Cancer Treatments and Mutations (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and Blood groups and transfusion (1 paper). The work is most often cited by research in Hematology (172 citations), Genetics (59 citations), Oncology (144 citations), Rheumatology (72 citations) and Public Health, Environmental and Occupational Health (88 citations). Richard Pilot has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Jane F. Apperley, Hagop M. Kantarjian, Alan K. Hatfield, Gianantonio Rosti, Jörge E. Cortes, Patricia Ault, Mark A. Socinski, Amy Ko, Philip T. Sager and Barbara Balser. Their work appears in journals such as Blood, Frontiers in Oncology, European Journal of Cancer, British Journal of Clinical Pharmacology and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.